Reduced Intensity Allogeneic Transplantation Provides High Event-Free And Overall Survival In Patients With Advanced Indolent B Cell Malignancies: CALGB 109901
- Citation:
- Biol Blood Marrow Transplant vol 17 (9) 1395-1403
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 1
- Parents:
- 68
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Transplant
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, CA77597, CA04457, CA11789, U10 CA077658, CA03927, U10 CA031946, U10 CA033601, U10 CA047559-21, CA59518, CA60138, U10 CA077597, U10 CA059518, U10 CA047559, CA47559, CA77658, CA37135, CA31946, U10 CA003927
- Corr. Author:
- Authors:
- Thomas Shea Jeffrey Johnson Peter Westervelt Sherif Farag John McCarty Asad Bashey Luis Isola Lee-Anne Baxter-Lowe Michael Kelly Kouros Owzar Charles Linker
- Networks:
- Study
- CALGB-109901
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Article